Hormones

Ganirelix, explained simply

A fertility-treatment injection that prevents eggs from being released too early during IVF cycles.

Well studied in peopleInjection under the skin (like insulin shots)4 cited sources

Start here

What is Ganirelix?

Ganirelix is an FDA-approved fertility medicine injected under the skin during IVF treatment. It blocks the hormone surge that would make eggs release too early, letting doctors control exactly when eggs mature and can be retrieved ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}. Its safety was established in controlled trials of 794 women ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}.

How it works in your body

Ganirelix works like a lock that prevents the key (GnRH) from opening the door to egg release. Unlike agonists (compounds that switch a receptor on) that initially stimulate before shutting down, ganirelix immediately blocks the GnRH receptors, preventing the LH surge that triggers ovulation. During IVF, this gives doctors precise control over when eggs mature and can be retrieved, dramatically improving success rates.

The deeper mechanism, for the curious

Ganirelix is a lab-made chain of 10 amino acids (a decapeptide) based on the natural hormone GnRH, with swaps at positions 1, 2, 3, 6, 8 and 10. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} It competes with GnRH for its receptors on the pituitary (the master hormone gland at the base of the brain) gonadotroph (the hormone-making cell in the pituitary gland). This quickly and reversibly lowers the release of gonadotropins (hormones that control the ovaries), more for LH than for FSH, and without the initial burst of hormone that GnRH agonists (compounds that switch a receptor on) cause. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} During controlled ovarian stimulation (fertility treatment that grows several eggs), it is given once a day under the skin from the middle to late follicular phase (the first half of the menstrual cycle) until the day of the hCG trigger (the shot that finishes egg maturation). This prevents a premature LH surge. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Levels peak about 1 hour after injection, absolute bioavailability (the share that reaches the blood) is 91.1%, and the half-life (how long it stays active in your body) is about 13 hours after one dose and 16 hours at steady state (when levels stop building up), which is reached after 3 days. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}

Evidence check

Well studied in people

This has been through large human trials — the strongest kind of evidence. Scientists have tested it on many people and measured what actually happened.

Every numbered marker on this page links to one of the 4 sources at the bottom.

94/100

Ovulation Control

Allows doctors to control exactly when ovulation happens

90/100

IVF Success Improvement

Improves success rates in IVF cycles

87/100

Safety and OHSS prevention (a painful ovary overreaction)

Prevents premature LH surge that can ruin egg quality

What the research points to

Prevents a premature LH surge (an early spike of luteinizing hormone that triggers egg release too soon) that can ruin egg quality ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
Lets doctors control exactly when ovulation (egg release) happens ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
Works quickly compared to other hormone treatments ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
Improves success rates in IVF cycles
Lowers the risk of OHSS (ovarian hyperstimulation syndrome, a painful overreaction of the ovaries to fertility drugs)
Better timing control means more mature eggs at retrieval

The most-asked question

How much Ganirelix do I take?

The research-reported range is 250 mcg, once daily.

IVF / controlled ovarian stimulation, Preventing premature LH surge
250 mcg
- How often
  Once daily during the mid-to-late follicular phase
- For how long
  Continued daily until the day of hCG administration (typically about 5-9 days)
- How
  Injection under the skin
FDA-labeled dose for inhibiting premature LH surges during controlled ovarian stimulation; started after several days of FSH and continued until hCG trigger ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}.

Adjusting your dose

You're at the right dose if…

Therapeutic goals being met with minimal side effects
Stable and consistent response to treatment
Lab values or clinical markers trending in the right direction
Good tolerance with manageable or absent side effects

Consider going up if…

You've tolerated the current dose for the recommended period without significant side effects
Therapeutic goals haven't been met at the current dose level
Your healthcare provider recommends dose escalation based on your response
Lab work or clinical assessments support a higher dose

Go down if…

Side effects are bothersome or impacting daily life despite management strategies
You experience any signs of an adverse reaction
Lab results indicate the need for dose reduction
Your healthcare provider recommends a lower dose based on your response

The ceiling: 250 mcg once daily — the only labelled dose. In the dose-finding trial, 500–2000 mcg gave lower pregnancy rates (6.7–13.6% per attempt) than 250 mcg (35.7%). ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}

Reconstitution, in plain words

How do I mix Ganirelix?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Ganirelix:

What you need

Ganirelix vial (lyophilized powder or solution)
Bacteriostatic water or sterile sodium chloride for reconstitution
Alcohol swabs for cleaning vial tops and injection sites
Appropriately sized syringes with fine-gauge needles (27-30 gauge)
Sharps disposal container

A worked example

Add the recommended volume of bacteriostatic water to the Ganirelix vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.

Working out your dose

Your dose of Ganirelix is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Ganirelix's recorded schedule.

GanirelixOnce daily during the mid-to-late follicular phase

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.

Injection sites & technique

Where do I inject Ganirelix?

The best spots

Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
Front of thighs—middle to upper portion of the outer leg
Back of upper arm—outer area (may need assistance from another person)

How to do it, step by step

Wash your hands thoroughly with soap and water before handling supplies
Clean the injection site with an alcohol swab and let it air dry completely
Pinch a fold of skin at the chosen injection site
Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
Inject the medication slowly and steadily over 5-10 seconds
Release the skin fold and remove the needle, applying gentle pressure with a clean swab
Rotate injection sites to prevent tissue irritation or lipodystrophy (lumps or dents in the fat under the skin)
Dispose of the needle safely in a sharps container—never recap or reuse needles

Subcutaneous (under the skin) injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Timing

When do I take Ganirelix?

Best time of day

Administer Ganirelix at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.

With or without food?

Ganirelix injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.

Taking it with other peptides

Ganirelix should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Ganirelix cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

Mild discomfort at treatment site
Some users experience mild discomfort, which is among the most commonly reported effects with Ganirelix. This typically resolves within a few days as the body adjusts.
What to do Apply ice if needed. Rotate treatment sites. These symptoms typically improve within the first week of use.
Injection site reactions (redness, bruising, swelling)
Injection site reactions were reported in 1.1% of women in the label's controlled trials. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Redness, bruising or mild swelling can occur with repeated daily injections and typically does not require stopping treatment.
What to do Rotate injection sites daily between abdomen and thighs. Apply ice immediately after injection to reduce bruising. Avoid injecting in bruised areas. Use proper subcutaneous (under the skin) technique to minimize tissue trauma. Pain relief medication is rarely needed but available if desired.
Headaches
Headache was reported in 3.0% of women in the label's controlled trials. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} It is usually mild and may also reflect the hormonal changes of ovarian stimulation.
What to do Stay well hydrated throughout the stimulation cycle, aiming for 2-3 liters of water daily. Apply cool compresses to forehead or back of neck. Rest in a quiet, dark room if headache is bothersome. Acetaminophen or ibuprofen is safe to use (check with your clinic). Headaches usually improve on their own.
Abdominal pain
Gynecological abdominal pain was the most common adverse event in the label's controlled trials, at 4.8%; gastrointestinal abdominal pain was 1.0%. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Much of it reflects ovarian enlargement from FSH stimulation. Pain that suddenly worsens can signal ovarian hyperstimulation syndrome (2.4% in the trials). ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
What to do Heat application (heating pad on low setting for 15-20 minutes) often provides relief. Wear comfortable, loose clothing. Avoid strenuous exercise and intercourse. Gentle walking is fine. Over-the-counter pain relievers are usually adequate. Contact your clinic if pain suddenly worsens or is severe, as this could indicate ovarian hyperstimulation.
Pelvic discomfort
A sense of pelvic heaviness or fullness comes mainly from ovarian enlargement during FSH stimulation. The label's controlled trials list gynecological abdominal pain at 4.8% and no separate pelvic-discomfort figure. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
What to do Rest when possible. Wear supportive, loose-fitting clothing. Avoid heavy lifting and strenuous activity. Warm baths may ease discomfort. Stay hydrated. Pelvic discomfort is expected and not dangerous unless accompanied by severe pain, which requires immediate clinic contact.
Nausea
Nausea was reported in 1.1% of women in the label's controlled trials. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} It is usually mild and resolves without stopping treatment.
What to do Eat small, frequent meals rather than three large ones. Avoid greasy, fried, or strong-smelling foods. Ginger candies or ginger tea can help settle nausea. Stay hydrated with clear fluids. Take anti-nausea medication only if approved by your clinic, as some medications affect egg quality. Nausea usually resolves spontaneously.
Fatigue or dizziness
Fatigue and dizziness are not among the adverse events reported in at least 1% of women in the label's controlled trials. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} When they occur during a cycle they are more often linked to stimulation, sleep or hydration.
What to do Prioritize adequate sleep and rest, aiming for 7-8 hours nightly. Rise slowly from lying or sitting positions to prevent orthostatic dizziness. Stay well hydrated. Avoid excessive heat (hot showers, saunas). Moderate, gentle exercise like walking may help maintain energy. Report persistent severe dizziness to your clinic immediately.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

Severe allergic reaction
In rare cases, Ganirelix may trigger a severe allergic reaction including difficulty breathing, facial swelling, or widespread rash. This requires immediate medical attention.
What to do STOP treatment immediately and seek emergency medical care. Do not restart without medical clearance. Report all allergic reactions to your healthcare provider.

Week by week

What should I expect from Ganirelix, and when?

Day 1-4
You might notice
- Start FSH injections to stimulate egg growth
- Not yet started
What's normal
- Initial response to Ganirelix is beginning at the cellular level
- Different individuals experience Ganirelix's onset at different rates
- Transient systemic (affecting the whole body) effects from initial Ganirelix exposure are common
What's next
- Maintain consistent Ganirelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Day 5-6
You might notice
- When leading follicle reaches 14mm, start daily ganirelix injections
- Begin 250 mcg once daily
What's normal
- Ganirelix is binding to its targets in your body and starting to work
- Initial mechanism of Ganirelix is taking effect
- Early transient effects from Ganirelix administration are resolving
What's next
- Maintain consistent Ganirelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Day 7-12
You might notice
- Continue both the FSH shots (the follicle-growing hormone) and ganirelix, with frequent ultrasound monitoring
- Continue the same dose unless adjusted by your doctor
What's normal
- Ganirelix is binding to its targets in your body and starting to work
- Initial mechanism of Ganirelix is taking effect
- Early transient effects from Ganirelix administration are resolving
What's next
- Maintain consistent Ganirelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Day 10-14
You might notice
- When 2-3 follicles reach 18mm, receive hCG trigger shot to finalize egg maturation
- Take final dose same evening as trigger
What's normal
- Ganirelix is binding to its targets in your body and starting to work
- Initial mechanism of Ganirelix is taking effect
- Early transient effects from Ganirelix administration are resolving
What's next
- Maintain consistent Ganirelix administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Day 11-15
You might notice
- Egg retrieval procedure 34-36 hours after hCG trigger
- Stopped - cycle complete
What's normal
- Ganirelix response patterns are emerging
- Initial Ganirelix response is consistent with mechanism expectations
- Early tolerance development to Ganirelix is not expected
What's next
- Assess whether Ganirelix response aligns with expectations
- Plan next steps based on initial Ganirelix tolerance and response
- Establish baseline monitoring for Ganirelix response tracking

How to tell it's actually working

Treatment Response

Improvement in the primary symptoms or condition being treated
Positive changes in relevant lab values or clinical markers
Consistent, stable response to Ganirelix over time
Reduction in symptom frequency or severity

General Well-being

Improved energy levels and daily functioning
Better quality of life related to the treated condition
Manageable or absent side effects indicating good tolerance
Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
Insufficient time at target dose—most compounds need several weeks to show full benefits
Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
Individual variation in response—genetics, metabolism, and other factors affect outcomes
Underlying conditions or medications interfering with absorption or effectiveness
Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Ganirelix?

Do not use it if…

Pregnancy or suspected pregnancy
Breastfeeding
Known allergies to any medication component
Ovarian cysts larger than 3cm

Be extra careful if…

You are taking other medications—discuss potential interactions with your healthcare provider
You have a history of liver or kidney disease
You are elderly or have multiple medical conditions
You are planning surgery in the near future—inform your surgeon about Ganirelix use
You have any chronic health conditions that require regular monitoring

When to stop

Severe or worsening side effects that don't improve with dose adjustment or supportive care
Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
Your healthcare provider recommends discontinuation based on your clinical response
Development of any new medical condition that may be contraindicated with Ganirelix
Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
Abnormal lab results or clinical markers that suggest adverse effects

Ganirelix should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

Avoid
Other GnRH antagonists (like cetrorelix) in the same cycle
Use with caution—discuss with your healthcare provider.
Avoid
Certain herbal supplements that affect hormones
Use with caution—discuss with your healthcare provider.

Other peptides

OK together
FSH (follicle-stimulating hormone) for egg growth
May be used together under medical guidance.
OK together
hCG (human chorionic gonadotropin) to trigger final egg maturation
May be used together under medical guidance.
OK together
GnRH agonists in certain protocol variations
May be used together under medical guidance.

Supplements

OK together
Multivitamins
Generally safe to take alongside Ganirelix. Space doses apart if taking oral formulations to ensure optimal absorption.
OK together
Electrolyte supplements
Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Improving IVF or ICSI (injecting a single sperm into an egg) success rates

Ganirelix is particularly well-suited for individuals focused on improving ivf or icsi success rates. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Preventing premature ovulation during egg retrieval cycles

Ganirelix is particularly well-suited for individuals focused on preventing premature ovulation during egg retrieval cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Controlling the growth of eggs with fertility drugs (ovarian stimulation) in women with unpredictable cycles

Ganirelix is particularly well-suited for individuals focused on controlling ovarian stimulation in women with unpredictable cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

The safety picture overall

Ganirelix is an FDA-approved GnRH antagonist (it blocks the brain signal that triggers ovulation). Its safety was evaluated in 794 women in two controlled clinical trials, with treatment lasting 1–14 days. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Side effects were infrequent: gynecological abdominal pain 4.8%, headache 3.0%, ovarian hyperstimulation syndrome (OHSS, a painful overreaction of the ovaries) 2.4%, vaginal bleeding 1.8%, and injection site reactions and nausea 1.1% each. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Hypersensitivity (allergic) reactions, including anaphylaxis (a severe, life-threatening allergic reaction), angioedema (sudden swelling of the face, lips, or throat) and urticaria (hives), have been reported after marketing, sometimes with the first dose; the needle shield on some syringes contains natural rubber latex. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Because it blocks the GnRH receptor directly, it does not cause an initial release of gonadotropins (the brain hormones FSH and LH that drive the ovaries). ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}

Effectiveness rests on two trials: a double-blind dose-finding study in 332 women, in which 250 mcg gave the best pregnancy rate (35.7% per attempt, against 6.7–13.6% at 500–2000 mcg), and an open-label study in 463 women, in whom a premature LH surge occurred in under 1%. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} In the controlled trials, 11.9% had a neutrophil count (a type of white blood cell) of at least 8.3 × 10⁹/L, and hematocrit (the share of blood made up of red cells) and total bilirubin (a pigment cleared by the liver) shifted downward; the label says the clinical significance was not determined. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} An observational study of more than 1,000 newborns found birth defect rates comparable to cycles using GnRH agonists (compounds that switch a receptor on). ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}

Keeping it good

How do I store Ganirelix?

Before mixing (powder)

Store at 77°F (25°C); brief excursions between 59°F and 86°F (15–30°C) are permitted. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Protect from light. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Check the expiration date before use.

After mixing (liquid)

Not applicable — ganirelix is a colorless, ready-to-use solution in a single-dose prefilled syringe; nothing is mixed. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Use each syringe once and discard any unused portion. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024} Air bubbles in the syringe are expected and do not need to be removed. ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}

Signs it has gone bad

Solution is not colorless or contains visible particles ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
Product has been exposed to temperatures outside the recommended storage range
Syringe has already been used — each prefilled syringe is single-dose ^{4Source 4Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024}
Expiration date has passed
Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Ganirelix

2025

Elagolix Represents a Less Invasive and Cheaper Option Than Injectable GnRH Antagonist for Ovulation Suppression in IVF

Retrospective cohort (a look back at past patient records) of 269 IVF patients: oral elagolix 50 mg every other day (173) lowered LH (luteinizing hormone) as well as daily injectable ganirelix or cetrorelix (96), with similar egg numbers, maturity, fertilization, blastocyst (5-6 day embryo) and euploidy (normal chromosome count) rates; pregnancy outcomes were not assessed.

Mouanness M, et al.

2023

Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation

Cochrane review of 14 RCTs (randomized controlled trials) with 2,643 women on oral progestogens (progesterone-type pills) to prevent the LH surge: compared with GnRH antagonists, there may be little or no difference in cancellation of oocyte (egg) pick-up (low-certainty evidence), and the effects on live birth are very uncertain.

Glujovsky D, et al.

2023

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for prevention of ovarian hyperstimulation syndrome

Randomised trial in 156 women at high risk of OHSS (ovarian hyperstimulation syndrome, a painful overreaction of the ovaries to fertility drugs) after freeze-all (all embryos frozen for later): cetrorelix 0.25 mg plus letrozole and mifepristone lowered moderate/severe OHSS to 20.5% from 42.3% with mifepristone alone, with similar cumulative live birth rates (74.4% vs 76.9%). The antagonist used was cetrorelix, not ganirelix.

Qi Q, et al.

2024

Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)

FDA label: ganirelix acetate 250 mcg is injected under the skin once daily during the middle to late follicular phase (the first half of the menstrual cycle) to prevent premature LH surges (early spikes of luteinizing hormone) in women undergoing controlled ovarian stimulation (fertility treatment that grows several eggs); continued daily until the day of hCG administration (the shot that finishes egg maturation).

U.S. Food and Drug Administration

If this isn't the right fit

What people use instead of Ganirelix

Alternative approaches for hormone support support

Consult your healthcare provider for alternatives to Ganirelix based on your specific needs and medical history

Alternative hormone-supporting peptides

Kisspeptin-10
Gonadorelin
PT-141 (Bremelanotide)

Non-peptide hormone support

Clomiphene citrate
Anastrozole
Lifestyle modifications (sleep, exercise)

Your questions

Ganirelix FAQ

How fast does ganirelix work?

Ganirelix starts suppressing LH levels within 1-2 hours of injection. Full suppression is achieved within 24 hours, making it much faster than GnRH agonists (compounds that switch a receptor on) that can take 2-3 weeks to work.

Why is blocking LH (luteinizing hormone, which triggers egg release) so important for IVF?

Your body naturally releases eggs on its own schedule through an LH surge. In IVF, doctors need to control the timing to retrieve mature eggs. Without ganirelix, the LH surge would release eggs before they're optimally mature, ruining the cycle. Ganirelix gives doctors complete control.

How is ganirelix different from cetrorelix?

Both are GnRH antagonists (drugs that block the brain signal that triggers ovulation). Studies show cetrorelix may suppress LH slightly better and carry a lower risk of OHSS (ovarian hyperstimulation syndrome, a painful overreaction of the ovaries to fertility drugs). Ganirelix works equally well for most patients and may act faster for some. Your doctor chooses based on your situation.

Are the injections painful?

Most patients describe them as relatively painless since they're small needles used for subcutaneous (under the skin) injection. However, repeated injections can cause bruising. Rotating sites and using ice can minimize discomfort.

Can ganirelix affect pregnancy if I'm already pregnant?

Ganirelix should NOT be used if you're pregnant or suspect you are. Always do a pregnancy test before starting a new IVF cycle. If you become pregnant during treatment, stop immediately and contact your doctor.

What happens if I miss a dose?

Take the missed dose as soon as you remember, unless it's almost time for your next dose. Missing a single dose might allow an LH surge, potentially compromising that cycle. Call your fertility clinic immediately if you miss a dose.

Can I use ganirelix at home?

Yes! Ganirelix comes in a pre-filled syringe that's easy to self-inject at home. Most patients inject into the abdomen or thigh. Your fertility clinic will teach you the technique before your cycle starts.

How many eggs does ganirelix help retrieve?

Ganirelix doesn't determine egg quantity - FSH does that. Ganirelix's job is preventing premature ovulation so those eggs can be retrieved when ready. Studies show it helps increase the percentage of mature eggs (which improves quality).

4 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Ganirelix research profile on Peptide Initiative.

Elagolix Represents a Less Invasive and Cheaper Option Than Injectable GnRH Antagonist for Ovulation Suppression in IVFMouanness M, et al. · 2025
Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulationGlujovsky D, et al. · 2023
Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for prevention of ovarian hyperstimulation syndromeQi Q, et al. · 2023
Ganirelix Acetate Injection 250 mcg/0.5 mL - FDA Prescribing Information (DailyMed)U.S. Food and Drug Administration · 2024

Want the deep science?

Read the full Ganirelix research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More hormones guides

This guide is education, not medical advice. Talk to a clinician before taking anything.